Cancer Treatment Reviews
Volume 29, Issue 1 , Pages 21-30 , February 2003

Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review

  • Johnny Kao

      Affiliations

    • Department of Radiation and Cellular Oncology, The University of Chicago, 5758 South Maryland MC 9006, Chicago, IL 60637, USA
    • Corresponding Author InformationCorrespondence to: Johnny Kao MD, Department of Radiation and Cellular Oncology, The University of Chicago, 5758 South Maryland MC 9006, Chicago, IL 60637, USA. Tel.: 1-773-702-6870; Fax: 1-773-702-0610.
    • ,
  • Michael C Garofalo

      Affiliations

    • Department of Radiation and Cellular Oncology, The University of Chicago, 5758 South Maryland MC 9006, Chicago, IL 60637, USA
    • ,
  • Michael T Milano

      Affiliations

    • Department of Radiation and Cellular Oncology, The University of Chicago, 5758 South Maryland MC 9006, Chicago, IL 60637, USA
    • ,
  • Steven J Chmura

      Affiliations

    • Department of Radiation and Cellular Oncology, The University of Chicago, 5758 South Maryland MC 9006, Chicago, IL 60637, USA
    • ,
  • Jason R Citron

      Affiliations

    • Department of Radiation and Cellular Oncology, The University of Chicago, 5758 South Maryland MC 9006, Chicago, IL 60637, USA
    • ,
  • Daniel J Haraf

      Affiliations

    • Department of Radiation and Cellular Oncology, The University of Chicago, 5758 South Maryland MC 9006, Chicago, IL 60637, USA
    • The University of Chicago Cancer Research Center, 5758 South Maryland MC 9006, Chicago, IL 60637, USA

References 

  1. Forastiere A, Koch W, Trotti A, et al.  Head and neck cancer. N. Engl. J. Med. 2001;345:1890–1900
  2. Vokes EE, Weichselbaum RR, Lippman SM, et al.  Head and neck cancer. N. Engl. J. Med. 1993;328:184–194
  3. Million R, Cassisi N, Clark J. Cancer of the head and neck. In: Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott; 1989;p. 488–590
  4. Kies MS, Haraf DJ, Rosen F, et al.  Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J. Clin. Oncol. 2001;19:1961–1969
  5. Williams R. Recurrent head and neck cancer: the results of treatment. Br. J. Surg. 1974;61:691–697
  6. Ridge J. Squamous cell cancer of the head and neck:surgical treatment of local and regional recurrence. Semin. Oncol. 1993;20:419–429
  7. Murphy B, Li Y, Cella D, et al.  Phase III study comparing cisplatin and 5-fluorouracil versus cisplatin and paclitaxel in metastatic/recurrent head and neck cancer. Proc. Am. Soc. Clin. Oncol. 2001;20:894a
  8. Jacobs C, Meyers F, Hendrickson C, et al.  A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study. Cancer. 1983;52:1563–1569
  9. Jacobs C, Lyman G, Velez-Garcia E, et al.  A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J. Clin. Oncol. 1992;10:257–263
  10. Bendahmane B, Bontemps P, Bourgeois H, et al.  Final results of phase II study of patients with metastatic or recurrent squamous cell carcinoma of the head and neck treated with docetaxel and 5-fluorouracil. Proc. Am. Soc. Clin. Oncol. 2000;19:1656a
  11. Forastierre AA, Metch B, Schuller DE, et al.  Randomized comparison of cisplatin+fluorouracil and carboplatin+fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck: A Southwest Oncology Group study. J. Clin. Oncol. 1992;10:1245–1251
  12. Burtness BA, Li Y, Flood W, et al.  Phase III trial comparing cisplatin and placebo to cisplatin and anti-epidermal growth factor antibody C225 in patients with metastatic/recurrent head and neck cancer. Proc. Am. Soc. Clin. Oncol. 2002;21:901a
  13. The Liverpool Head and Neck Oncology Group. A phase III randomized trial of cisplatinum, methotrexate, cisplatinum+methotrexate and cisplatinum+5-FU in end stage squamous cell carcinoma of the head and neck. Br J Cancer 1990;61: 311–315
  14. Haraf DJ, Weichselbaum RR, Vokes EE. Reirradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. Ann. Oncol. 1996;7:913–918
  15. Haraf DJ, Chung K, Stenson M, et al.  High dose re-irradiation with concomitant chemotherapy for local/regionally recurrent head and neck cancer (NHC): results in 48 patients. Proc. Am. Soc. Clin. Oncol. 2000;19:413a
  16. Stevens KR, Britsch A, Moss WT. High dose reirradiation of head and neck cancer with curative intent. Int J. Radiat. Oncol. Biol. Phys. 1994;29:687–698
  17. Dawson LA, Myers LL, Bradford CR, et al.  Conformal reirradiation of recurrent and new primary head and neck cancer. Int J. Radiat. Oncol. Biol. Phys. 2001;50:377–385
  18. Emami B, Bignardi M, Spector GJ, et al.  Reirradiation of recurrent head and neck cancers. Laryngoscope. 1987;97:85–88
  19. Pomp J, Levendag PC, van Putten WL. Reirradiation of recurrent tumors in the head and neck. Am. J. Clin. Oncol. 1988;11:543–549
  20. Spencer SA, Wheeler , Peters GE, et al.  Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck. Am. J. Clin. Oncol. 1999;22:1–5
  21. Gandia D, Wibault P, Guillot T, et al.  Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer. Head Neck. 1993;15:8–15
  22. De Crevoisier R, Bourhis J, Domenge C, et al.  Full dose reirradiation for unresectable head and neck carcinoma. Experience at the Gustave Roussy Institute in a series of 169 patients. J. Clin. Oncol. 1998;16:3556–3562
  23. Weppelmann B, Wheeler RH, Peters GE, et al.  Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation. Int. J. Radiat. Oncol. Biol. Phys. 1992;22:1051–1056
  24. Benchalal M, Bachaud JM, Francois P, et al.  Hyperfractionation in the reirradiation of head and neck cancers. Result of a pilot study. Radiother. Oncol. 1995;36:203–210
  25. Spencer SA, Harris J, Wheeler RH, et al.  RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 2001;51:1299–1304
  26. Wang CC. Reirradiation of recurrent nasopharyngeal carcinoma—treatment techniques and results. Int. J. Radiat. Oncol. Biol. Phys. 1987;13:953–956
  27. Wang CC, McIntyre J. Reirradiation of laryngeal carcinoma—techniques and results. Int. J. Radiat. Oncol. Biol. Phys. 1993;26:783–785
  28. Teo PM, Kwan WH, Chan AT, et al.  How successful is high dose (⩾60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?. Int. J. Radiat. Oncol. Biol. Phys. 1998;40:897–913
  29. Jemal A, Thomas A, Murray T, et al.  Cancer statistics. CA Cancer J. Clin. 2002;52:23–47
  30. Fremgen AM, Bland KI, McGinnis LS, et al.  Clinical highlights from the national cancer database. CA Cancer J. Clin. 1999;49:145–158
  31. Al-Sarraf M, Pajak TF, Byhardt RW, et al.  Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced resectable head and neck cancers: RTOG 88-24. Int. J. Radiat. Oncol. Biol. Phys. 1997;37:777–782
  32. Brizel DM, Albers ME, Fisher SR, et al.  Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N. Engl. J. Med. 1998;338:1798–1804
  33. Forastiere AA, Berkey B, Maor M, et al.  Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, Intergroup trial R 91-11. Prog. Proc. Am. Soc. Clin. Oncol. 2001;20:2a
  34. Fu KK, Pajak TF, Trotti A, et al.  A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int. J. Radiat. Oncol. Biol. Phys. 2000;48:7–16
  35. Hong W, Bromer R, Amato D, et al.  Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer. 1985;45:1242–1245
  36. Kotwall C, Sako K, Razack MS, et al.  Metastatic patterns in squamous cell cancer of the head and neck. Am. J. Surg. 1987;154:439–442
  37. Nishijima W, Takooda S, Tokita N, et al.  Analyses of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy. Arch. Otolaryngol Head Neck Surg. 1993;119:65–68
  38. Mabanta SR, Mendenhall WM, Stringer SP, et al.  Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck. 1999;21:591–594
  39. Rubin P. The law and order of radiation sensitivity, absolute vs. relative. In:  Vaeth JM,  Meyer JL editor. Radiation Tolerance of Normal Tissues. Frontiers of Radiation Therapy and Oncology. Basel, Switzerland: Karger; 1989;p. 7–40
  40. Lee AW, Foo W, Law SC, et al.  Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement. Int. J. Radiat. Oncol. Biol. Phys. 1997;38:43–52
  41. Ang KK, Jiang GL, Feng Y, et al.  Extent and kinetics of recovery of occult spinal cord injury. Int. J. Radiat. Oncol. Biol. Phys. 2001;50:1013–1020
  42. Nieder C, Milas L, Ang KK. Tissue tolerance to reirradiation. Semin. Radiat. Oncol. 2000;10:200–209
  43. Weichselbaum RR, Beckett MA, Schwartz JL, et al.  Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int. J. Radiat Oncol. Biol. Phys. 1988;15:575–579
  44. Peiffert D, Pernot M, Malissard L. Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases. Int J. Radiat. Oncol. Biol. Phys. 1994;29:681–686
  45. Langlois D, Hoffstetter S, Malissard L, et al.  Salvage irradiation of oropharynx and mobile tongue with iridium 192 brachytherapy in Centre Alexis Vautrin. Int J. Radiat. Oncol. Biol. Phys. 1988;14:849–853
  46. Hong WK, Bromer R. Chemotherapy in head and neck cancer. Current concepts. N Engl. J. Med. 1983;308:75–79
  47. Richards GJ, Chambers RG. Hydroxyurea: a radiosensitizer in the treatment of neoplasms of the head and neck. Am J. Roentgenol Radium. Ther. Nucl. Med. 1969;105:555–565
  48. Byfield JE, Calabro-Jones P, Klisak I, et al.  Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays. Int J Radiat. Oncol. Biol. Phys. 1982;8:1923–1933
  49. Frankfurt OS. Enhancement of the antitumor activity of 5-fluorouracil by drug combinations. Cancer Res. 1973;33:1043–1047
  50. Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J. Clin. Oncol. 1990;8:911–934
  51. Pignon JP, Bourhis J, Domenge C, et al.  Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three metaanalyses of updated individual data. MACH-NC Collaborative Group. Metaanalysis of chemotherapy on head and neck cancer. Lancet. 2000;355:949–955
  52. De Crevoisier R, Domenge C, Wibault P, et al.  Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer. 2001;91:2071–2076
  53. Hwang JM, Fu KK, Phillips TL. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma. Int J. Radiat Oncol. Biol. Phys. 1998;41:1099–1111
  54. Chua DT, Sham JS, Kwong DL, et al.  Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment. Int J. Radiat. Oncol. Biol. Phys. 1998;41:379–386
  55. Levendag PC, Meeuwis CA, Visser AG. Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy. Radiother. Oncol. 1992;23:6–15
  56. Langlois D, Exchwege F, Kramar A, et al.  Reirradiation of head and neck cancers. Presentation of 35 cases treated at the Gustave Roussy Institute. Radiother. Oncol. 1985;3:27–33
  57. Stell PM. Time to recurrence of squamous cell carcinoma of the head and neck. Head Neck. 1991;13:277–278
  58. Johnson LS, Milliken BD, Hadley SW, et al.  Initial clinical experience with a video based patient positioning system. Int J Radiat. Oncol. Biol. Phys. 1999;45:205–213
  59. Mauceri HJ, Hanna NN, Beckett MA, et al.  Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature. 1998;394:287–291

PII: S0305-7372(02)00096-8

doi: 10.1016/S0305-7372(02)00096-8

Cancer Treatment Reviews
Volume 29, Issue 1 , Pages 21-30 , February 2003

Article Tools

* Image Usage & Resolution